Apyx Medical (APYX) Receivables Refunds (2019 - 2023)

Apyx Medical has reported Receivables Refunds for 5 years, with the latest figure at $7.8 million in Q2 2023.

• For the quarter ending Q2 2023, Receivables Refunds rose 1.44% year-over-year to $7.8 million; the trailing twelve-month figure through Jun 2023 stood at $7.8 million (up 1.44% YoY), and the FY2022 full-year result was $7.5 million, down 1.27% from the prior year.
• Receivables Refunds for Q2 2023 stood at $7.8 million, roughly flat from $7.8 million in the prior quarter.
• The five-year high for Receivables Refunds was $7.8 million in Q1 2023, with the low at $426000.0 in Q4 2019.
• Historically, Receivables Refunds has averaged $6.9 million across 5 years, with a median of $7.6 million in 2021.
• Annual changes were most pronounced in 2020 — Receivables Refunds surged 1696.71% — and 2022, when it declined 1.42%.
• Apyx Medical's Receivables Refunds stood at $426000.0 in 2019, then surged by 1696.71% to $7.7 million in 2020, then decreased by 0.16% to $7.6 million in 2021, then slipped by 1.27% to $7.5 million in 2022, then rose by 2.74% to $7.8 million in 2023.
• The last three Receivables Refunds figures came in at $7.8 million (Q2 2023), $7.8 million (Q1 2023), and $7.5 million (Q4 2022), per Business Quant data.